Different responsiveness to nitric oxide-cyclic guanosine monophosphate pathway in cholinergic and tachykinergic contractions of the rabbit iris sphincter muscle

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 9, 1997, Pages 1719-1725

  Chuman, Hideki ^a   Chuman, Tomomi ^a   Nao i, Nobuhisa ^a   Sawada, Atsushi ^a   Yamamoto, Ryuichi ^a   Kobayashi, Hideyuki ^a   Wada, Akihiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Cholinergic and tachykinergic contractions; Cyclic guanosine monophosphate; Nitric oxide; Rabbit iris sphincter muscle; Sodium nitroprusside

Indexed keywords

8 BROMO CYCLIC GMP; CARBACHOL; CYCLIC GMP; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NEUROKININ A; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE; CONTROLLED STUDY; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; SPHINCTER PUPILLAE MUSCLE;

ANIMALS; CARBACHOL; CYCLIC GMP; CYCLIC N-OXIDES; FEMALE; FREE RADICAL SCAVENGERS; IMIDAZOLES; IRIS; MALE; MOTOR ACTIVITY; MUSCARINIC AGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NEUROKININ A; NITRIC OXIDE; NITROPRUSSIDE; RABBITS; RADIOIMMUNOASSAY;

EID: 0030848778     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ueda N, Muramatsu I, Sakakibara Y, Fujimura M. Non-cholinergic, nonadrenergic contraction and substance P in rabbit iris sphincter muscles. Jpn J Pharmacol. 1981;31:1071-1079.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
3. Ignarro LJ, Buga GM, Wood KS, Byrns WE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein in nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265-9269.
4. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1-21.
5. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
6. Furchgott RF. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol Scand. 1989;138:257-270.
7. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol. 1991;41:485-490.
8. Lee TJ-F, Sarwinski S. Nitric oxidergic neurogenic vasodilation in the porcine basilar artery. Blood Vessels. 1991;28:407-412.
9. Yamamoto R, Wada A, Asada Y, et al. Functional relation between nitric oxide and norepinephrine for the modulation of vascular tone in rat mesenteric vasculature. Naunyn Schmiedebergs Arch Pharmacol. 1994; 349:362-366.
10. Yamamoto R, Wada A, Asada Y, et al. Nitric oxide-dependent and -independent norepinephrine release in rat mesenteric arteries. Am J Physiol. (Heart Circ Physiol) 1997;272:H207-H210.
11. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
12. Ahlner J, Andersson RGG, Torfgard K, Axelsson KL. Organic nitrate esters: Clinical use and mechanisms of actions. Pharmacol Rev. 1991;43:351-423.
13. Chuman T, Chuman H, Nao-i N, Sawada A, Yamamoto R, Wada A. Nitric oxide-sensitive and -insensitive contractions of the isolated rabbit iris sphincter muscle. Invest Ophthalmol Vis Sci. 1996;37:1437-1443.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
15. Yousufzai SYK, Chen A-L, Abdel-Latif AA. Species differences in the effects of prostaglandins on inositol triphosphate accumulation, phosphorylation and contraction in iris sphincter of the mammalian eye: Interaction with the cyclic AMP system. J Pharmacol Exp Ther. 1988;247:1064-1072.
16. Ueda N, Muramatsu I, Fujiwara M. Prostaglandins enhance trigeminal substance P-ergic responses in the rabbit iris sphincter muscles. Brain Res. 1985;337:347-351.
17. Akaike M, Yoshida M, Miyamoto Y, et al. Antagonistic action of imidazolineoxyl N-oxide against endothelium-derived relaxing factor/NO through a radical reaction. Biochemistry. 1993;32:827-832.
18. Yoshida M, Akaike T, Wada Y, et al. Therapeutic effects of imidazolineoxyl N-oxides against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun. 1994;202:923-930.
19. Wess J. Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol Sci. 1993;14:308-313.
20. Regoli D, Boudon A, Fauchére J-L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev. 1994;46:551-599.
21. Adbel-Latif AA. Calcium-mobilizing receptors, polyphosphoinositides, generation of second messengers and contraction in the mammalian iris smooth muscle: Historical perspectives and current status. Life Sci. 1989;45:757-786.
22. Taniguchi T, Ninomiya H, Fukunaga R, Ebii K, Yamamoto M, Fujiwara M. Neurokinin A-stimulated phosphoinositide breakdown in rabbit iris sphincter muscle. Jpn J Pharmacol. 1992;59:213-220.
23. Tachado SD, Akhtar RA, Yousufzai SYK, Abdel-Latif AA. Species differences in the effects of substance P on inositol triphosphate accumulation and cyclic AMP formation, and on contraction in isolated iris sphincter of the mammalian eye: Differences in receptor density. Exp Eye. Res. 1991;53:729-739.
24. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
25. G-nitro L-arginine. Invest Ophthalmol Vis Sci. 1994;35:3673-3680.
26. Jacquemin E, de Kozak Y, Thillaye B, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats. Invest Ophthalmol Vis Sci. 1996;37:1187-1196.